A Study to Evaluate the Toxicity of Combined Sunitinib and Radiation Therapy (RT) as Neoadjuvant Treatment of Extremity and Retroperitoneal Soft Tissue Sarcoma (STS).
Phase of Trial: Phase I
Latest Information Update: 26 May 2016
At a glance
- Drugs Sunitinib (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions
- 26 May 2016 New trial record